Moreover, the increased sCD14 levels in NASH patients were highly correlated with increased hepatic CD14 expression and liver inflammation, even after adjusting for age, sex, presence of diabetes, dyslipidemia, hypertension, BMI, VFA, and SFA. This evidence concerns the gene CD14 and diabetes mellitus.